Update on human African trypanosomiasis (sleeping sickness)

Kennedy, P. G.E. (2019) Update on human African trypanosomiasis (sleeping sickness). Journal of Neurology, 266, pp. 2334-2337. (doi: 10.1007/s00415-019-09425-7) (PMID:31209574)

[img]
Preview
Text
188588.pdf

74kB

Abstract

Human African trypanosomiasis (HAT), also known as sleeping sickness, is one of the Africa's 'neglected diseases' and is caused by infection with protozoan parasites of the Trypanosoma genus. Transmitted by the bite of the tsetse fly, it puts 70 million people at risk throughout sub-Saharan Africa and is usually fatal if untreated or inadequately treated. In this brief overview, some important recent developments in this disease are outlined. These cover various aspects including a reduction in disease incidence, newly recognised parasite reservoir sites in humans, disease outcome, novel diagnostic methods, new and improved treatment, and disease neuropathogenesis.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Kennedy, Professor Peter
Authors: Kennedy, P. G.E.
College/School:College of Medical Veterinary and Life Sciences > Institute of Infection Immunity and Inflammation
Journal Name:Journal of Neurology
Publisher:Springer
ISSN:0340-5354
ISSN (Online):1432-1459
Published Online:17 June 2019
Copyright Holders:Copyright © 2019 Springer-Verlag GmbH Germany, part of Springer Nature
First Published:First published in Journal of Neurology 266:2334–2337
Publisher Policy:Reproduced in accordance with the copyright policy of the publisher

University Staff: Request a correction | Enlighten Editors: Update this record